Cargando…
PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429029/ http://dx.doi.org/10.1097/01.HS9.0000976068.87162.cb |
| _version_ | 1785090613373304832 |
|---|---|
| author | Zhang, Zhipeng LI, Wen Wu, Wenzhong Liu, Hong Yang, LI Lu, Kai Ren, Haijuan Lin, Zenghua |
| author_facet | Zhang, Zhipeng LI, Wen Wu, Wenzhong Liu, Hong Yang, LI Lu, Kai Ren, Haijuan Lin, Zenghua |
| author_sort | Zhang, Zhipeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429029 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290292023-08-17 PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA Zhang, Zhipeng LI, Wen Wu, Wenzhong Liu, Hong Yang, LI Lu, Kai Ren, Haijuan Lin, Zenghua Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429029/ http://dx.doi.org/10.1097/01.HS9.0000976068.87162.cb Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zhang, Zhipeng LI, Wen Wu, Wenzhong Liu, Hong Yang, LI Lu, Kai Ren, Haijuan Lin, Zenghua PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title | PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title_full | PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title_fullStr | PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title_full_unstemmed | PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title_short | PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA |
| title_sort | pb2337: short-term efficacy and safety of zanubrutinib combined with pomalidomide in the treatment of central nervous system lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429029/ http://dx.doi.org/10.1097/01.HS9.0000976068.87162.cb |
| work_keys_str_mv | AT zhangzhipeng pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT liwen pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT wuwenzhong pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT liuhong pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT yangli pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT lukai pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT renhaijuan pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma AT linzenghua pb2337shorttermefficacyandsafetyofzanubrutinibcombinedwithpomalidomideinthetreatmentofcentralnervoussystemlymphoma |